טוען...
Potentiated Anti-tumor Effects of BETi by MEKi in Anaplastic Thyroid Cancer
Anaplastic thyroid cancer (ATC) is an aggressive malignancy with limited treatment options. We explored novel treatment modalities by targeting epigenetic modifications using inhibitors of BET (e.g. BRD4) activity. We evaluated the efficacy in the treatment of ATC of a novel BET inhibitor, PLX51107...
שמור ב:
| הוצא לאור ב: | Endocr Relat Cancer |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6938575/ https://ncbi.nlm.nih.gov/pubmed/31272080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-19-0107 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|